MGBase is a registry created in 2021 to compile online data on myasthenic patients worldwide:
- it is directly inspired by a registry developed for multiple sclerosis (MSBase), which collected data from 107,000 patients.
- In three years, MGBase has recorded the clinical and immunological data of 565 patients with myasthenia gravis included by 16 centres operating in eight different countries.
- 70% of patients had anti-RACh autoantibodies and 7% had anti-MuSK autoantibodies,
- 33% had an ocular form.
Led by Australians, this registry does in fact present a recruitment bias within the cohort. However, geographical diversification is underway. In May 2025, the registry contained data from 1,225 patients from 15 different countries.
